Company SeaStar Medical Holding Corporation

Equities

ICU

US81256L1044

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 21:00:00 26/04/2024 BST 5-day change 1st Jan Change
0.4402 USD -8.79% Intraday chart for SeaStar Medical Holding Corporation +8.69% -0.56%

Business Summary

SeaStar Medical Holding Corporation is a commercial-stage medical technology company. The Company is focused on developing extracorporeal therapies to reduce the consequences of hyperinflammation on vital organs. The Company's technologies rely on science to provide life-saving solutions to critically ill patients. The Company develops and commercializes cell-directed extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company uses its Selective Cytopheretic Device (SCD) technology platform to clinically validate several acute organ injury indications, including kidneys and lungs. Its investigational SCD is an extracorporeal synthetic membrane device designed to integrate into existing continuous renal replacement therapy (CRRT) systems that are commonly installed in hospitals throughout the United States.

Number of employees: 12

Managers

Managers TitleAgeSince
Chief Executive Officer 51 31/12/18
Director of Finance/CFO 61 01-09
Chief Operating Officer - 01/12/22
Chief Tech/Sci/R&D Officer 51 30/06/22
Corporate Officer/Principal 56 27/10/22

Members of the board

Members of the board TitleAgeSince
Director/Board Member 76 31/12/20
Chairman 64 -
Director/Board Member 60 31/12/20
Director/Board Member 63 31/12/21
Director/Board Member 60 31/12/21
Chief Executive Officer 51 31/12/18
Director/Board Member 58 31/12/18

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 75,419,458 63,795,195 ( 84.59 %) 0 84.59 %

Shareholders

NameEquities%Valuation
DOW INC.
11.38 %
7,416,396 11.38 % 5 M $
2,587,500 3.972 % 2 M $
3i LP
1.866 %
1,215,690 1.866 % 892 316 $
840,110 1.290 % 616 641 $
752,500 1.155 % 552 335 $
Vanguard Group, Inc. (Subfiler)
0.4017 %
261,671 0.4017 % 192 067 $
Goldman Sachs & Co. LLC
0.3402 %
221,626 0.3402 % 162 673 $
Kevin Chung
0.3345 %
217,912 0.3345 % 159 947 $
159,964 0.2455 % 117 414 $
Geode Capital Management LLC
0.1683 %
109,650 0.1683 % 80 483 $
NameEquities%Valuation
Ayrton Capital LLC
-
250,000 - 36 500 $
Boothbay Fund Management LLC
-
245,200 - 35 799 $
Linden Advisors LP
-
218,073 - 31 839 $
Yakira Capital Management, Inc.
-
200,157 - 29 223 $
Warberg Asset Management LLC
-
193,600 - 28 266 $
Walleye Capital LLC
-
188,300 - 27 492 $
RiverNorth Capital Management LLC
-
150,000 - 21 900 $
Walleye Trading LLC
-
125,600 - 18 338 $
LMR Partners LLP
-
125,000 - 18 250 $
Context Capital Management LLC
-
124,107 - 18 120 $

Company contact information

Seastar Medical Holding Corp.

3513 Brighton Boulevard Suite 410

80216, Denver

+

http://www.seastarmedical.com
address SeaStar Medical Holding Corporation(ICU)
  1. Stock Market
  2. Equities
  3. ICU Stock
  4. Company SeaStar Medical Holding Corporation